Study design (if review, criteria of inclusion for studies)
double-blind double-placebo crossover study
Participants
20 children with cystic fibrosis
Interventions
enteric coated microspheres (ECM) with an enteric coated tablet (ECT) pancreatic enzyme preparation
Outcome measures
Steatorrhoea was assessed by 3 day faecal fat analysis and dosage of medication, stool frequency and consistency; abdominal pain and appetite were documented by a patient-kept diary card.
Main results
ECM controlled steatorrhoea (11.8 +/- 9.2 g vs 23.2 +/- 18.9 g, P less than 0.02), stool frequency (1.7 +/- 0.6 vs 2.1 +/- 0.9, P less than 0.01) and abdominal pain (8.8 +/- 13.8 vs 23.4 +/- 24.1, P less than 0.05) significantly better than ECT. Out of 20 patients 17 preferred ECM to ECT (P less than 0.00036).
Authors' conclusions
ECM preparations should allow more satisfactory dietary management of patients with cystic fibrosis with longterm beneficial effect.